Jump Financial, LLC Regenxbio Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$12.89 - $20.82 $462,415 - $746,896	35,874 New	35,874 $643,000
Q2 2023 Aug 07, 2023	BUY	$17.23 - $21.71 $821,819 - $1.04 Million	47,697 New	47,697 $953,000
Q2 2022 Aug 09, 2022	SELL	$19.35 - $35.04 $630,810 - $1.14 Million	-32,600 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$24.62 - $34.31 $802,612 - $1.12 Million	32,600 New	32,600 $1.08 Million
Q4 2021 Feb 10, 2022	SELL	$30.19 - $40.28 $455,053 - $607,140	-15,073 Closed	0 $0

Q3 2021 Nov 12, 2021	BUY	$29.09 - $45.68 $438,473 - $688,534	15,073 New	15,073 $632,000

193

42M

80.6K

55.2K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $458M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.